Text Size
32 studies found for:    mononucleosis

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
21 Active, not recruiting LMP1- and LMP2-Specific CTLs to Patients With EBV-Positive NPC (NATELLA)
Condition: Nasopharyngeal Carcinoma
Intervention: Genetic: Genetically modified CTLs
22 Completed Accelerated Immunization to Induce Cytomegalovirus Immunity in Stem Cell Donors
Condition: Cytomegalovirus Infections
Intervention: Drug: ALVAC-CMV (vCP260)
23 Recruiting LMP-specific T-cells for Patients With Relapsed EBV-positive Lymphoma
Conditions: Hodgkin Disease;   Non Hodgkin Lymphoma
Interventions: Biological: Injection of LMP Specific Cytotoxic T-Lymphocytes (group 1);   Biological: Injection of LMP Specific Cytotoxic T-Lymphocytes (group 2);   Biological: Injection of LMP Specific Cytotoxic T-Lymphocytes (group 3)
24 Completed Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations
Condition: Epstein-Barr Virus Infections
Intervention:
25 Recruiting EBV CTLs Expressing CD30 Chimeric Receptors For CD 30+ Lymphoma
Conditions: Hodgkin's Lymphoma;   Non-Hodgkin's Lymphoma
Intervention: Genetic: autologous CAR.CD30 EBV specific-CTLs
26 Active, not recruiting Blood T-Cells and EBV Specific CTLs Expressing GD-2 Specific Chimeric T Cell Receptors to Neuroblastoma Patients
Condition: Neuroblastoma
Intervention: Biological: 14g2a.zeta chimeric receptor transduced autologous EBV specific cytotoxic T-lymphocytes (EBV-CTL) w/o lymphodepletion
27 Active, not recruiting LMP2a-Specific Cytotoxic T-Lymphocytes Following CD45 Antibody for Lymphoma
Condition: Lymphoma
Interventions: Biological: CD45 antibodies;   Biological: EBV specific T cells
28 Recruiting Safety Study of Injections of Autologous/Allogeneic TGFbeta-resistant LMP2A-specific Cytotoxic T-lymphocytes (CTL)
Conditions: Lymphoma;   Hodgkin's Disease;   Relapse;   Lymphoma, Non-Hodgkin
Intervention: Genetic: TGF-b Resistant LMP2A-Specific Cytotoxic T-Lymphocytes
29 Recruiting Study of the T-cells or EBV Specific CTLs for Advanced B-Cell Non Hodgkin's Lymphoma and Chronic Lymphocytic Leukemia
Conditions: Non-Hodgkin Lymphoma;   Chronic Lymphocytic Leukemia
Intervention: Genetic: autologous or syngeneic PBTLs and EBV-CTLs
30 Recruiting CTLs Expressing CD19 Chimeric Receptors, CD19 Positive Malignancies Post SCT, MULTIPRAT
Conditions: Stem Cell Transplant;   Acute Lymphoblastic Leukemia (ALL);   Chronic Lymphocytic Leukemia (CLL);   Non Hodgkin's Lymphoma
Intervention: Genetic: CD19CAR/virus specific T cells
31 Completed Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)
Condition: Epstein-Barr Virus Infections
Intervention: Biological: Intravenous injection of EBV specific CTLS
32 Recruiting Administration of Rapidly Generated Multivirus-specific Cytotoxic T-Lymphocytes (VIRAGE)
Conditions: Adenovirus Infection;   Epstein-Barr Virus Infections;   Cytomegalovirus Infections;   Stem Cell Transplant
Intervention: Biological: Multi-virus Specific T cells
To Top

Show previous page of results Previous Page (1-20) Studies Shown (21-32) Next Page
† Indicates status has not been verified in more than two years